Lymphomation.org > Treatments

Antibodies (monoclonal) such as Rituxan

Balancing therapy-related risks  and benefits

Biologics  Interferon, Neupogen, Leukine ...

Bone marrow (stem cell) transplants  

Allogeneic: Mini / Autologous / Cord 
Auto versus Allo SCT   
HLA-typing and Background
Harvesting / Mobilizing stem cells 
Graft vs Host Disease | Patient stories  Resources   

Chemotherapy

Alphabetical index of agents
Agents grouped by mechanism  
CHOP chemotherapy  
Common chemo protocols (APO...VBM)  
Liposomal (encapsulated) types 
Low dose (metronomic) chemotherapy PEP-C Outcome abstracts - Frontline Treatment support for chemotherapy

Clinical Trials

Search tools

Complementary and Alternative Medicine

Elderly patients - treatment protocols and resources

Emerging Therapies and Targets index of investigative therapies &  treatment targets, containing brief explanations.
 
     Also see Pipeline with links to clinical trials

Evaluating medical claims recognizing bias; limits of abstracts, what makes information credible.

Graft vs Host Disease

Immune-based therapies

Lower toxic treatments  

MDS (Myelodysplastic Syndrome)

Nanotechnology

Photopheresis 

Pipeline new agents with links to clinical trials

Pregnancy During Lymphoma Treatment

Progress Review Group  (PRG) research objectives

Radio-immunotherapy

Bexxar  ... centers 
Zevalin  ... centers 
Comparing Bexxar/Zevalin 
RIT for bulky disease?

Refractory lymphomas  
protocols for lymphomas resistant to standard therapies

Protocols | Clinical Trials

Remissions & Response background & terms

Also Spontaneous regressions

Rituxan - Basics ... Side effects ...
 
               Check list what to expect, bring, do.

     Abstracts | Maintenance? 

Side effects common to treatments

Splenectomy

Stem cell Transplant

Surgery for Lymphoma? (a common question)

Treatments & Decisions

Goals | Types | Outcomes | Interventions  

PROTOCOL TYPES:
  Standard Off-label ... etc. 

BEST PRACTICE (Standard of Care):

NCCN.org  PDF (login req.)
  
NCI  Cancer.gov

Treatment decisions - factors that can influence treatment goal, type, and timing and
 
         Considerations at relapse

Experts on treatment

Treatment outcome abstracts

Treatment Support 

Treatment Timing?

Time to Progression comparing protocols for first line treatment of indolent NHL | Frontline

Treatment settings frontline, relapse, survival

Watchful Waiting

Transformation background and treatment

Vaccines  investigational patient-specific therapeutic vaccines

Categorized abstracts | Outcome Data

What's a Drug?